Your Trusted Pharmaceutical Wholesaler Partner
As a Swiss pharmaceutical wholesaler, we play a key role in the healthcare supply chain by ensuring the efficient distribution of medicines and healthcare products from manufacturers to pharmacies, hospitals, and healthcare providers across Switzerland and worldwide.
Operating under strict Swiss regulatory standards, we guarantee the quality, safety, and traceability of pharmaceutical products throughout the entire logistics process. With modern storage facilities, GDP-compliant cold-chain logistics, temperature-controlled transport, and advanced inventory systems, we ensure that medicines are delivered quickly, safely, and reliably to healthcare providers and patients.
Sourcing of Unlicensed Medicines and Medicine Shortages in Hospitals
We source and import unlicensed and unregistered medicines for rare conditions, leveraging our global network to deliver therapies that are not yet available in Switzerland or other markets.
Our expertise includes the handling of high-value and temperature-sensitive products, supported by fully GDP-certified cold-chain logistics. We support healthcare providers in maintaining continuity of patient care by sourcing medicines that are temporarily unavailable or in short supply.
Through our international network of trusted suppliers, we rapidly identify and secure the required products. Our team manages all regulatory requirements, import procedures, and logistics, ensuring that essential treatments reach pharmacies, hospitals, and patients without delay. With a strong focus on speed, reliability, and regulatory compliance, we help the Swiss healthcare system mitigate the impact of supply disruptions and ensure access to critical medicines when they are needed most.
Clinical Trial Supply
We are a Comparator Sourcing Company, Investigational Medicinal Products (IMPs), and unlicensed therapies for clinical trials in Switzerland, the United States, Europe and across Asia.
Our services include:
Comparator sourcing through our global supplier network
Compliant importation, labelling, and release testing in accordance with Swissmedic and EU Clinical Trial Regulation (CTR) requirements
Temperature-controlled storage and distribution to clinical trial sites
Full documentation management and pharmacovigilance support for trial sponsors
Early Access Programs & Named Patient Supply
Our company specializes in Early Access Programs (EAP) and Named Patient Supply (NPS), enabling patients and healthcare professionals to access innovative therapies before they become commercially available in their country. Through structured Early Access Programs, we facilitate the ethical and compliant provision of investigational or pre-approved medicines to patients with serious or life-threatening conditions who have no satisfactory treatment alternatives. We collaborate closely with pharmaceutical companies, healthcare providers, and regulatory authorities to ensure that access pathways are managed efficiently and in full compliance with applicable regulations.
We also manage Named Patient Supply, allowing physicians to request specific medicines for individual patients when those treatments are not yet authorized or available in their market. Our team coordinates the entire process, including regulatory compliance, documentation, importation, and secure logistics. In Switzerland, under Article 49 of the Swiss Therapeutic Products Act (TPA), we facilitate managed access programs and named patient supply, providing early access to innovative therapies for patients with life-threatening or severely debilitating diseases.
By combining regulatory expertise, operational efficiency, and a strong commitment to patient access, we help bridge the gap between medical innovation and patients in need.
Partnership with Small Bioscience Companies
Your Swiss Partner for Market Entry and Beyond
For small and emerging bioscience companies, bringing an innovative orphan drug or specialty medicine to Switzerland can be complex. At Swiss Global Pharma, we simplify the process from start to finish.
Our services include:
Importing and Documentation
Full management of import permits, customs clearance, and regulatory documentation to ensure efficient entry into Switzerland.End-to-End Distribution
From sourcing medicines to final delivery to hospitals, clinics, pharmacies, physicians, and patients, ensuring full traceability and compliance throughout the supply chain. Whether your product has orphan designation or several years of remaining patent exclusivity, we offer flexible and low-risk partnership models to accelerate patient access without requiring a local legal entity.
Swiss Global Pharma can be your gateway to the Swiss market.
Regulatory & Market Access Support
We provide regulatory support for the registration of pharmaceutical products in Switzerland. We support pharmaceutical and healthcare companies throughout the entire regulatory process required to obtain market authorization in the Swiss market.
Our services include the preparation and submission of regulatory documentation, coordination with the Swiss regulatory authority, and ongoing support to ensure compliance with local regulations, including regulatory strategy, reliance on FDA or EMA approvals where applicable, reimbursement dossiers with the competent authority.